Trials / Completed
CompletedNCT00345046
A Comparison of Three Different Formulations of Prednisolone Acetate 1%
A Comparison of Three Different Formulations of Topical Prednisolone Acetate 1% for Control of Post Glaucoma and/or Cataract Surgery Inflammation.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Indiana University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Generic prednisolone acetate 1% is less effective than Pred Forte 1% or Econopred Plus 1%.
Detailed description
Overall Study Design: Structure: This is a randomized, double-masked prospective study. The study medications will be masked and randomized by the outpatient pharmacy at Indiana University Hospital. Duration: Treatment duration: The duration of each subject's participation will be for up to 2 months after surgery. One hundred and two subjects will be enrolled over a twelve-month time span. Controls: Examiner, staff, and subjects are masked. Parallel group comparison. Dosage/Dose Regimen/Instructions: Subjects scheduled for glaucoma and/or cataract surgery will be recruited. Subjects may not be currently on any steroid or ophthalmic non-steroidal anti-inflammatory (NSAID) therapy for a minimum of 6 weeks prior to surgery. Subjects will be randomized to receive a dose of Pred Forte 1% (Allergan), Econopred Plus 1% (Alcon) or prednisolone acetate 1% (Falcon) four times a day starting immediately after finishing the surgery for two weeks, then twice a day for two more weeks. After 1 month of therapy subjects will stop or continue steroid treatment based on clinical findings. No other subconjunctival steroid or ointment will be used intra-operatively or post-operatively. The eye drop will be instilled per labeling instructions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pred Forte | Four drops daily decreasing to once daily over four weeks. |
| DRUG | EconoPred Plus | Prednisolone Acetate four times daily decreasing to once daily over four weeks. |
| DRUG | Prednisolone Acetate | Dosed four times daily decreasing to once daily over four weeks. |
Timeline
- Start date
- 2002-09-01
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
- First posted
- 2006-06-27
- Last updated
- 2015-06-03
- Results posted
- 2014-04-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00345046. Inclusion in this directory is not an endorsement.